trending Market Intelligence /marketintelligence/en/news-insights/trending/QiwLpvxaQ2gmDQdgTI23Gg2 content esgSubNav
In This List

Integra LifeSciences acquires Rebound Therapeutics

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Integra LifeSciences acquires Rebound Therapeutics

Integra LifeSciences Holdings Corp. acquired medical-device maker Rebound Therapeutics Corp. to add to its portfolio of neurosurgical products and therapeutic-focused offerings.

The Irvine, Calif-based Rebound Therapeutics manufactures single-use medical devices for visualization, diagnostic and therapeutic use in neurosurgery.

Plainsboro, N.J.-based Integra, which develops, manufactures and sells surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics and general surgery, does not expect the deal to have a material financial impact in 2019.

Integra recently acquired neurosurgical-device maker Arkis BioSciences Inc. in July to enhance its product offerings in neurocritical care.